Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001544227-21-000026
Filing Date
2021-04-29
Accepted
2021-04-29 16:09:01
Documents
16
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A mlnd-20201231.htm   iXBRL 10-K/A 408748
2 EX-31.3 mlnd-20201231xex313.htm EX-31.3 10176
3 EX-31.4 mlnd-20201231xex314.htm EX-31.4 10206
  Complete submission text file 0001544227-21-000026.txt   679482

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mlnd-20201231.xsd EX-101.SCH 2423
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT mlnd-20201231_cal.xml EX-101.CAL 710
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT mlnd-20201231_def.xml EX-101.DEF 1643
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mlnd-20201231_lab.xml EX-101.LAB 34963
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mlnd-20201231_pre.xml EX-101.PRE 18576
9 EXTRACTED XBRL INSTANCE DOCUMENT mlnd-20201231_htm.xml XML 16946
Mailing Address 110 MILLER AVENUE, SUITE 100 ANN ARBOR MI 48104
Business Address 110 MILLER AVENUE, SUITE 100 ANN ARBOR MI 48104 734-845-9000
Millendo Therapeutics, Inc. (Filer) CIK: 0001544227 (see all company filings)

EIN.: 451472564 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-35890 | Film No.: 21870589
SIC: 2834 Pharmaceutical Preparations